Evolution Wealth Advisors, LLC Catalent, Inc. Transaction History

Evolution Wealth Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$119.57 - $139.07 $7,413 - $8,622	-62 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$109.17 - $142.35 $11,790 - $15,373	-108 Reduced 63.53%	62 $8,000
Q2 2021 Jul 22, 2021	SELL	$100.34 - $115.69 $2,307 - $2,660	-23 Reduced 11.92%	170 $18,000
Q1 2021 Apr 20, 2021	SELL	$101.51 - $125.27 $2,639 - $3,257	-26 Reduced 11.87%	193 $20,000
Q4 2020 Feb 02, 2021	SELL	$85.88 - $105.36 $13,740 - $16,857	-160 Reduced 42.22%	219 $23,000
Q3 2020 Oct 15, 2020	SELL	$72.74 - $92.5 $4,946 - $6,290	-68 Reduced 15.21%	379 $32,000
Q2 2020 Jul 27, 2020	SELL	$48.02 - $79.04 $4,994 - $8,220	-104 Reduced 18.87%	447 $33,000
Q1 2020 Apr 22, 2020	BUY	$36.95 - $62.95 $1,699 - $2,895	46 Added 9.11%	551 $29,000
Q4 2019 Feb 03, 2020	SELL	$47.06 - $56.64 $2,164 - $2,605	-46 Reduced 8.35%	505 $28,000
Q3 2019 Nov 12, 2019	SELL	$47.45 - $58.05 $1,470 - $1,799	-31 Reduced 5.33%	551 $26,000
Q2 2019 Jul 12, 2019	BUY	$39.26 - $54.21 $22,849 - $31,550	582 New	582 $32,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Evolution Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Evolution Wealth Advisors, LLC with notifications on news.